Following a tough period with headwinds from China and the transformation of Diagnostics, we expect the positive underlying trends to show through. Imaging, the backbone of the company, should profit from market share gains in volume and especially value terms from its unique photon-counting CT technology and from the market expansion by its Helium-free MRI scanner. For Diagnostics, we see only upside for investors from the two possible scenarios, a continuation of the turnaround or a potential ...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ARCELOR MITTAL, CELLNEX, SECTOR AUTOPISTAS, TALGO. EUROPA: AIRBUS, ING GROEP, PERNOD RICARD, SIEMENS, SOCIÉTÉ GÉNÉRALE. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’24 que se publicarán en España y Europa en los próximos días. El Ibex sigue imparable La sesión volvió a estar marcada por los comentari...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.